Company news
J. Molner AS news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
J. Molner AS: Audited Consolidated Annual Report 2025
June 8, 2026
J Molner acquires US commercial pharmaceutical portfolio from Nordic Pharma, Inc.
June 2, 2026
J Molner acquires J Molner Holdings Inc. and enters into a loan agreement
June 1, 2026
Changes in the Capital Structure of J. Molner AS
May 26, 2026
Subsidiary of J. Molner AS entered into a commercial pledge agreement
April 29, 2026
Changes in the capital structure of J. Molner AS
January 9, 2026
Additional increase of The J. Molner Company OÜ voluntary reserve
December 30, 2025
Increase of J. Molner share capital in connection with a capital structure adjustment transaction
December 18, 2025
Decisions of the shareholders - adoption of resolutions of the General Meeting without calling a meeting
December 5, 2025
J Molner launches Clobetasol Propionate Cream USP, 0.05% (Emollient) in the United States
November 14, 2025
J Molner extension of Management Board Member terms of office
September 1, 2025
J Molner announces changes in the management of The J. Molner Company LLC
June 6, 2025
Notice of J. Molner AS Regarding the Adoption of a Shareholders' Resolution Without Convening a General Meeting
May 5, 2025
Option Agreement Signed with Key Employee
April 25, 2025
J. Molner AS: Audited Consolidated Annual Report 2024
April 21, 2025
The subsidiary of J. Molner AS The J. Molner Company OÜ was granted an additional loan
December 10, 2024
J Molner strengthens US market position with new product development agreement
December 10, 2024
J Molner Announces Approval and Upcoming Market Launch of Desoximetasone Ointment USP, 0.05%
December 4, 2024
J Molner launches Lidocaine HCL Topical Solution USP, 4% in the United States
November 12, 2024
J Molner Announces New Chief Financial Officer
October 22, 2024